Does UBROGEPANT Cause Off label use? 132 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Off label use have been filed in association with UBROGEPANT (UBRELVY). This represents 5.2% of all adverse event reports for UBROGEPANT.
132
Reports of Off label use with UBROGEPANT
5.2%
of all UBROGEPANT reports
2
Deaths
4
Hospitalizations
How Dangerous Is Off label use From UBROGEPANT?
Of the 132 reports, 2 (1.5%) resulted in death, 4 (3.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBROGEPANT. However, 132 reports have been filed with the FAERS database.
What Other Side Effects Does UBROGEPANT Cause?
Drug ineffective (656)
Migraine (399)
Nausea (210)
Headache (204)
Dizziness (111)
Fatigue (92)
Somnolence (87)
Therapeutic product effect incomplete (69)
Vomiting (67)
Pain (61)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which UBROGEPANT Alternatives Have Lower Off label use Risk?
UBROGEPANT vs ULIPRISTAL
UBROGEPANT vs UMBRALISIB
UBROGEPANT vs UMECLIDINIUM
UBROGEPANT vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UBROGEPANT vs UMIFENOVIR